Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

APC Pharmacy/Facility Members (PFMs) are entitled to exceptional value opportunities through several hand-picked affinity service providers.

We’re pleased to introduce our newest one: Rx Advisors.

Rx Advisors is a full-service accounting and tax firm specializing in independent pharmacies, with specific expertise in compounding pharmacies.

Pharmacy/Facility Members only are eligible to receive a 20% discount on income tax, bookkeeping, payroll, and business advisory services.

Interested in learning more or taking advantage of RxAdvisor’s free income tax review. Well, first you have to become a PFM. If you’ve already made that smart move, contact Rx Advisors’ Curtis Cole at curtis@fleming-advisors.com or 855.877.9807.